コンテンツへスキップ
Merck
すべての画像(4)

主要文書

安全性情報

15-116

Sigma-Aldrich

ATM/Chk2 Pathway Explorer Antibody MiniPack

Upstate®, from mouse, unconjugated

別名:

A-T, mutated, AT mutated, TEL1, telomere maintenance 1, homolog, ataxia telangiectasia mutated, ataxia telangiectasia mutated (includes complementation groups A, C

and D), ataxia telangiectasia mutated protein, human phosphatidylinositol 3-kinas

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
eCl@ss:
32160702
NACRES:
NA.41
結合体:
unconjugated
application:
ICC
IP
WB
thin layer chromatography (TLC)
クローン:
10H11.E12, monoclonal
7, monoclonal
AM9, monoclonal
化学種の反応性:
human (05-513SP,05-649SP, 05-740SP), mouse (05-649SP and 05-740SP), rat
citations:
2
テクニック:
immunocytochemistry: suitable
immunoprecipitation (IP): suitable
thin layer chromatography (TLC): suitable
western blot: suitable

由来生物

mouse

品質水準

結合体

unconjugated

抗体製品タイプ

primary antibodies

クローン

10H11.E12, monoclonal
7, monoclonal
AM9, monoclonal

化学種の反応性

human (05-513SP,05-649SP, 05-740SP), mouse (05-649SP and 05-740SP), rat

メーカー/製品名

Upstate®

テクニック

immunocytochemistry: suitable
immunoprecipitation (IP): suitable
thin layer chromatography (TLC): suitable
western blot: suitable

NCBIアクセッション番号

UniProtアクセッション番号

輸送温度

wet ice

ターゲットの翻訳後修飾

unmodified

遺伝子情報

human ... ATM(472)
mouse ... Atm(11920)
rat ... Atm(300711)

詳細

Pathway Explorer Antibody MiniPack:
Each Pathway Explorer Antibody Minipack contains three related antibodies as part of a signaling cascade or a combination of total and phosphorylated forms of key signaling targets. Each of the three antibodies are 30% the original pack size. Full size versions of each of the Pathway Explorer antibodies are available for sale individually under the same catalog number with the removal of “SP” off of each one (e.g. 05-591SP can be ordered as 05-591).

ATM:
Ataxia telangiectasia mutated kinase (ATM) and ataxia telangiectasia and Rad3-related kinase (ATR) are related kinases that regulate cell cycle checkpoints and DNA repair. Mutation in the ATM gene results in the autosomal recessive disease ataxia telangiectasia (AT). The identified substrates for ATM are p53, p95/NBS1, MDM2, Chk2, BRCA1, CtIP, 4E-BP1 and Chk1. The essential requirement for the substrates of ATM/ATR is S/TQ. Hydrophobic amino acids at positions -3 and -1, and negatively charged amino acids at position +1 are positive determinants for substrate recognition by these kinases. Positively charged residues surrounding the S/TQ are negative determinants for substrate phosphorylation. The complex phenotype of cells derived from patients with AT suggests that ATM has additional cellular substrates. In unirradiated cells, ATM is present as an inactive homodimer or multimer. Double-stranded breaks in DNA caused by ionizing radiation cause rapid ATM kinase activation through dissociation of this complex and ATM autophosphorylation at Ser1981.

Chk2:
The p53 tumor-suppressor gene integrates numerous signals that control cell life and death. Several novel molecules involved in p53 signaling, including Chk2, p53R2, p53AIP1, Noxa, PIDD, and PID/MTA2, were recently discovered. The checkpoint kinase Chk2 is the mammalian homologue of yeast Cds1/Rad53. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53. Chk2 serves as ATM downstream effector to mediate activation of p53. Chk2 also phosphorylates and activates BRCA1, the product of a tumor suppressor gene that is mutated in breast and ovarian cancer.

* See full size versions for corresponding references.

特異性

05-513SP: Other species not tested.
05-649SP and 05-740SP: Others not tested.
05-649SP and 05-740SP: Predicted to cross-react with rat based on sequence homology.

免疫原

05-649SP: Mixture of two GST fusion proteins corresponding to residues 1-223 and 217-543 of human Chk2;05-740SP: KLH-conjugated, synthetic peptide corresponding to amino acids 1974-1988 (SLAFEEG[pS]QSTTISS) of human ATM. The immunizing sequence has 11/12 identical amino acids in mouse and rat.;05-513SP: Full length human ATM. Clone AM9.
Epitope: 05-740SP:Ser1981

アプリケーション

Research Category
細胞シグナル伝達
Research Sub Category
細胞周期、DNA複製及び修復
This Antibody pack contains Anti-ATM Antibody, Anti-phospho-ATM Antibody (Ser1981), Anti-Chk2 Antibody validated for use in WB, ICC & IP.

包装

Each vial is 30% the size of the parent catalog number

構成

05-513SP Anti-ATM, clone AM9

05-740SP Anti-phospho-ATM (Ser1981),
clone 10H11.E12

05-649SP Anti-Chk2, clone 7

品質

05-649SP: Routinely evaluated by immunoblot on RIPA lysates from Jurkat cells, HeLa, 3T3/A31, or A431 cells.

Western Blot Analysis: 0.1-1 μg/mL of this lot detected Chk2 in RIPA lysates from Jurkat cells. A previous lot detected Chk2 in lysates from HeLa, 3T3/A31, and A431 cells.

05-740SP: Routinely evaluated by immunoblot on in crude lysates from irradiated HeLa cells.

Western Blot Analysis: 0.5 µg/mL of this lot detected phosphorylated ATM in crude lysates from irradiated HeLa cells.

05-513SP: Routinely evaluated by immunoblot on nuclear extract from Raji cells.

Western Blot Analysis:
1:250-1:1000 dilution of this lot detected ATM in a nuclear extract from Raji cells.

ターゲットの説明

05-649SP: 67 kDa;05-740SP:~370 kDa;05-513SP: 350 kDa

物理的形状

3 individual tubes containing either Anti-ATM, clone AM9; Anti-phospho-ATM (Ser1981), clone 10H11.E12; or Anti-Chk2, clone 7

保管および安定性

Stable for 1 year at -20°C from date of receipt.
For maximum recovery of product, centrifuge the vial prior to removing the cap.

アナリシスノート

Control
For 05-649SP use Jurkat cell lysate, HeLa cell lysate.

For 05-740SP use Irradiated HeLa cell lysates.

For 05-513SP use Raji cells

その他情報

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

法的情報

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください

保管分類コード

10 - Combustible liquids


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

毒物及び劇物取締法

キットコンポーネントの情報を参照してください

PRTR

キットコンポーネントの情報を参照してください

消防法

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を表示すべき危険物及び有害物

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を通知すべき危険物及び有害物

キットコンポーネントの情報を参照してください

カルタヘナ法

キットコンポーネントの情報を参照してください

Jan Code

キットコンポーネントの情報を参照してください


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Heparin-coated superparamagnetic nanoparticle-mediated adeno-associated virus delivery for enhancing cellular transduction.
Jun-Ho Hwang,Slgirim Lee,Eunmi Kim,Jung-Suk Kim,Chang-Ha Lee,Ik-Sung Ahn,Jae-Hyung Jang
International Journal of Pharmaceutics null

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)